Terry Dagnon

Terry Dagnon appears in our data through filings on Outlook Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 19 March 2020 to 20 April 2023.

In open-market terms, that means 3 purchases worth €53k on one side and 3 sales worth €699k on the other. On balance, insiders were net sellers of €646k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. 2023 to date brings no purchases and 1 sale.

In size, the median ticket on the buying side is €13k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 21 April 2023: an open-market sale of €538k, in Outlook Therapeutics, Inc. The latest purchase dates back some time: it was published 1,584 days ago, on 23 June 2022. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.